ADVFN UK Market News

Author: Fiona Craig

  • Oil rallies as renewed Middle East conflict fuels supply disruption fears

    Oil rallies as renewed Middle East conflict fuels supply disruption fears

    Oil prices surged on Monday, climbing more than $4 a barrel as escalating military tensions involving Israel, Iran and Lebanon raised fresh concerns about global energy supplies and diminished hopes for a near-term easing of the conflict.

    Brent crude futures gained $4.42, or 4.47%, to reach $97.15 a barrel by 0609 GMT. U.S. West Texas Intermediate crude futures rose $4.07, or 4.50%, to $94.61 a barrel.

    Strike on Iranian petrochemical facility rattles energy markets

    Investor concerns intensified after Israel confirmed attacks on military targets across Iran, including a strike on a petrochemical complex in the country’s southwest. The operation came despite reports that U.S. President Donald Trump had urged Israeli Prime Minister Benjamin Netanyahu to avoid further military action.

    Israel said it had targeted facilities within the Mahshahr petrochemical complex, marking the first reported attack on Iranian energy infrastructure since the ceasefire agreed on April 8. Iranian officials later acknowledged that sections of the facility had been damaged.

    The renewed hostilities have undermined expectations that the broader conflict could soon be resolved and have reduced optimism that oil shipments through the Strait of Hormuz will resume in the near future. Prior to the war, around 20% of global oil and liquefied natural gas trade passed through the strategic waterway.

    Crude prices rebound sharply after Friday’s decline

    Monday’s advance reversed the losses seen on Friday, when oil markets weakened on expectations that tensions between Washington and Tehran could ease.

    Even after recent fluctuations, crude prices remain almost 60% higher than they were before the conflict erupted in late February. However, they are still below the peaks reached in March, when Brent crude briefly traded close to $120 a barrel.

    Iran launched a fresh barrage of missiles against Israeli targets on Sunday in response to Israeli operations in Lebanon. Nevertheless, President Trump continued to express confidence that a wider peace agreement remains achievable.

    Tehran has repeatedly maintained that any broader deal with the United States must include a lasting ceasefire in Lebanon.

    Israel began military operations in Lebanon in March following rocket and drone attacks carried out by the Iran-backed Hezbollah movement. On June 3, Israel and Lebanon announced a ceasefire agreement following negotiations held in Washington.

    Tehran signals Hormuz reopening could come with new restrictions

    Markets were also closely watching comments from Iran’s ambassador to Russia, who suggested the Strait of Hormuz could reopen but under revised terms.

    “Of course, this strait will be open, but with new conditions to be determined by the Iranian and Omani authorities,” Ambassador Kazem Jalali told Russian newspaper Izvestia in an interview published on Monday.

    Iran maintains that shipping traffic through the Strait of Hormuz remains heavily restricted, while U.S. sanctions and maritime measures against Iranian ports continue to affect regional trade flows.

    Analysts question effectiveness of latest OPEC+ production increase

    Meanwhile, OPEC+ agreed on Sunday to raise oil production for a fourth consecutive time in four months in an effort to ease supply pressures.

    Despite the announcement, analysts believe the move will do little to increase actual supply. Several member countries remain unable to meet production targets due to logistical and operational constraints. The closure of the Strait of Hormuz continues to disrupt exports, while Russia’s output capacity has been affected by attacks on key infrastructure.

    “In the current market, the physical impact of such a decision would be close to zero,” Rystad Energy’s head of geopolitical analysis, Jorge Leon, said in a note to clients.

    With geopolitical tensions showing little sign of easing and major energy supply routes still under pressure, traders are continuing to brace for heightened volatility across global oil markets.

  • Gold retreats to lowest level since March as Fed outlook and oil rally weigh on sentiment

    Gold retreats to lowest level since March as Fed outlook and oil rally weigh on sentiment

    Gold prices moved lower on Monday, falling to an 11-week low as investors responded to stronger-than-expected U.S. economic data that reinforced expectations for higher interest rates, while a sharp rise in oil prices added to concerns over inflation.

    Spot gold declined 0.8% to $4,296.08 an ounce by 02:49 ET (06:49 GMT), its weakest level since March 23. August gold futures in the United States also fell, losing 1% to trade at $4,322.60 an ounce.

    The latest decline follows a steep sell-off on Friday, when bullion dropped more than 3% after the release of robust U.S. labour market figures prompted traders to reassess the likely path of Federal Reserve policy.

    Strong employment figures reduce expectations for rate cuts

    Government data released on Friday showed the U.S. economy added 172,000 jobs in May, comfortably surpassing market forecasts. Meanwhile, the unemployment rate remained unchanged at 4.3%.

    The stronger-than-anticipated employment report led investors to scale back expectations for interest-rate reductions in 2026, helping drive Treasury yields and the U.S. dollar higher. Both developments tend to weigh on gold because the metal offers no yield.

    “Despite the lack of consistent messaging in the labour market data, we now have a rate hike fully priced at the December FOMC meeting,” ING analysts said in a recent note.

    The U.S. Dollar Index traded little changed during Asian trading hours on Monday after climbing to its highest level in two months during the previous session.

    Rising Middle East tensions push crude prices higher

    Geopolitical risks also remained a key focus for markets after Israel reported strikes on military facilities in western and central Iran, as well as a petrochemical site near Mahshahr. The attacks marked one of the most significant strikes against Iranian energy infrastructure since the ceasefire agreed in April.

    The developments followed multiple rounds of Iranian missile launches targeting Israel in response to an earlier Israeli operation near Beirut.

    Oil prices surged close to 5% as traders reacted to the renewed hostilities. The move intensified concerns that rising energy costs could reignite inflationary pressures around the world and complicate monetary policy decisions.

    While gold often benefits from safe-haven demand during periods of geopolitical uncertainty, support from risk-averse investors was outweighed by the impact of a stronger dollar and expectations of tighter U.S. monetary policy.

    Precious metals broadly weaker

    The weakness extended across the precious metals sector. Silver fell 1.2% to $677.00 per ounce, while platinum lost 0.9% to trade at $1,764.58 per ounce.

    Industrial metals were mixed. Benchmark copper futures on the London Metal Exchange gained 0.3% to $13,543.33 a tonne, while U.S. copper futures edged 0.1% lower to $6.28 a pound.

  • IXICO strengthens scientific advisory board and expands Parkinson’s research partnerships (IXI)

    IXICO strengthens scientific advisory board and expands Parkinson’s research partnerships (IXI)

    IXICO (LSE:IXI) has reinforced its scientific leadership with the appointment of three internationally recognised neuroscience experts to its Scientific Advisory Board, while also launching new research initiatives aimed at advancing imaging biomarkers for Parkinson’s disease.

    The company announced that Professor Jeffrey Cummings, a leading authority in Alzheimer’s disease from the University of Nevada Las Vegas, Professor Charles DeCarli, a distinguished neurologist and Alzheimer’s researcher at the University of California, Davis, and Professor Stéphane Lehéricy, a renowned neuroradiology specialist at the Paris Brain Institute, have joined its advisory board.

    The appointments broaden IXICO’s expertise across both Alzheimer’s and Parkinson’s disease, supporting the company’s strategy of combining advanced imaging technologies, biomarker analytics and artificial intelligence to accelerate neurological drug development.

    Alongside the advisory board expansion, IXICO unveiled two new Parkinson’s-focused scientific collaborations.

    The first is a research partnership with the Paris Brain Institute (ICM), where the organisations will undertake a prospective study evaluating novel neuromelanin-sensitive MRI techniques as potential imaging biomarkers for Parkinson’s disease. The project will focus on refining MRI acquisition methods and applying advanced AI-based analysis to improve the reliability and reproducibility of the technology, with the aim of supporting its future use in clinical trials.

    In a separate development, IXICO’s Chief Scientific and Medical Officer, Robin Wolz, and Principal Biomarker Scientist, Kirsi Kinnunen, have been invited to join the Michael J. Fox Foundation’s MRI Advisory Committee. The committee brings together leading academic, industry and non-profit organisations to support the development, standardisation and validation of quantitative MRI biomarkers for Parkinson’s research. The initiative seeks to improve the measurement of disease progression and treatment response through greater collaboration on imaging protocols, data sharing and reproducibility standards.

    Commenting on the developments, Robin Wolz, Chief Scientific and Medical Officer of IXICO, said: “IXICO’s business proposition is grounded in science, which is why working with some of the world’s most important KOLs ensures the validation and clinical relevance of the services and technology we provide to the biopharma industry. In addition, adding further expertise and collaborative R&D activity, including our research collaboration with the Paris Brain Institute and participation in MRI biomarker advisory activities, IXICO further deepens its presence in the CNS space.”

    He added, “I’m delighted to welcome Jeff, Charlie and Stéphane to the Scientific Advisory Board adding knowledge and experience to an already strong group of advisors. We will continue to explore opportunities to work with the most important individuals and organisations pioneering progress towards better understanding, diagnosis, and treatment of neurodegenerative disease.”

  • Markets focus on Middle East conflict, AI uncertainty and Apple’s WWDC event: Dow Jones, S&P, Nasdaq, Wall Street Futures

    Markets focus on Middle East conflict, AI uncertainty and Apple’s WWDC event: Dow Jones, S&P, Nasdaq, Wall Street Futures

    Investors began the week navigating a mix of geopolitical tensions, concerns over artificial intelligence valuations and anticipation ahead of Apple’s (NASDAQ:AAPL) annual developers conference, where the company is expected to outline the next phase of its AI strategy.

    U.S. futures point to a mixed open

    At 03:32 ET (07:32 GMT), futures tied to the Dow Jones Industrial Average were down 102 points, or 0.25%, while S&P 500 futures gained 0.3% and Nasdaq 100 futures advanced 0.7%.

    The mixed performance followed a sharp sell-off on Wall Street on Friday. A stronger-than-expected U.S. employment report increased expectations that the Federal Reserve may need to maintain a tighter monetary stance or even raise rates later this year if energy-driven inflation accelerates.

    The S&P 500 posted a 2.64% decline, its worst daily performance of 2026, ending a nine-week winning streak. Technology stocks were particularly weak, with the Philadelphia Semiconductor Index falling more than 10% after Broadcom’s (NASDAQ:AVGO) quarterly results failed to meet the market’s elevated expectations surrounding AI-related growth.

    Commenting on the week ahead, Deutsche Bank analysts wrote: “What a backdrop for the main economic event of the week, namely Wednesday’s May U.S. CPI report.”

    They added: “The timing is critical with the [Fed]’s next policy meeting, and Kevin Warsh’s first as Chair, a week later. For a while now the case for hiking has looked notably stronger than the case for a cut and last Friday’s payrolls has hugely reinforced that.”

    Fresh Iran-Israel clashes unsettle investors

    Geopolitical concerns intensified after Iran and Israel exchanged new strikes, casting doubt on the future of a fragile ceasefire brokered by the United States.

    The renewed hostilities mark the first direct military confrontation between the two countries since the truce reached in April.

    Reports suggest the latest escalation began with an Israeli strike on Beirut, followed by retaliatory actions from Tehran and further Israeli attacks against targets in western and central Iran.

    The Wall Street Journal reported that Israel activated air-raid warning systems and intercepted a ballistic missile launched from Yemen. Iran’s Revolutionary Guards also claimed responsibility for attacks on military airbases in southern Israel.

    While President Donald Trump maintained that diplomatic efforts remain on track, an Iranian source involved in negotiations told MS NOW that a deal is “no longer feasible at this stage.”

    Oil extends gains amid supply concerns

    Brent crude climbed 5.1% to $97.81 per barrel as traders continued to assess the risks posed by disruptions around the Strait of Hormuz.

    The strategic shipping route remains a key concern for energy markets, given that roughly 20% of global oil and LNG flows pass through the waterway.

    Rising crude prices have reignited fears that inflation could accelerate once again, potentially forcing central banks to keep borrowing costs elevated.

    RBC analysts noted that “it seems as though good news is being treated as bad news if it stokes fears of higher interest rates.”

    Gold pressured by rates outlook and stronger dollar

    Gold prices fell to their lowest level in eleven weeks as investors reassessed the outlook for interest rates.

    Higher borrowing costs tend to reduce the appeal of non-yielding assets such as gold, while continued demand for the U.S. dollar has provided an additional headwind for bullion.

    ING analysts said: “The geopolitical backdrop is also shifting dollar-positive, with most surprised that Brent is not trading even higher now that Iran and Israel are directly exchanging fire.”

    Apple’s AI strategy under the spotlight

    Attention is also turning to Apple’s Worldwide Developers Conference, which begins on Monday and is expected to feature a range of AI-related announcements.

    Investors are looking for evidence that Apple can close the perceived gap with rivals in the race to commercialise artificial intelligence technologies.

    The company has faced criticism following delays to planned Siri upgrades and a lukewarm response to some of its initial AI initiatives.

    According to BofA Global Research, “The key announcements to watch include an enhanced Siri experience, progress on Gemini-enabled Apple AI, potential Siri app, and broader app-intent and developer tools that could help define Apple’s agentic AI roadmap.”

  • Market Open: Tate & Lyle Takeover, Audioboom Record Performance

    Market Open: Tate & Lyle Takeover, Audioboom Record Performance

    FTSE 100 edges higher as oil jumps on Middle East tensions. Tate & Lyle agrees takeover while Audioboom ends sale process after record trading.

    Market Overview

    European markets weakened as geopolitical tensions in the Middle East weighed on sentiment. The FTSE 100 edged higher by 0.11 per cent, while the CAC 40 and DAX fell 0.32 per cent and 0.75 per cent respectively. In the United States, markets were more resilient, with the Nasdaq rising 1.16 per cent and the S&P 500 gaining 0.74 per cent. Investors continued to assess the impact of renewed Iran-Israel hostilities, while concerns around artificial intelligence valuations also contributed to caution across European equities.

    Commodity markets reflected the geopolitical backdrop, with Brent crude surging as traders responded to escalating conflict risks and concerns over energy supply routes. Copper advanced modestly, while gold remained softer despite safe-haven demand. Natural gas declined and Bitcoin weakened against sterling. Currency markets were relatively stable, with sterling strengthening against the euro, yen and Australian dollar, while slipping slightly against the US dollar.

    Market Numbers

    FTSE 100: Up (0.11%), 10,345.29

    CAC40: Down (-0.32%), 8,218.240

    DAX: Down (-0.75%), 24,759.05

    NASDAQ: Up (1.16%), 29,185.8

    S&P 500: Up (0.74%), 7,412.0

    In the Headlines

    Takeover Agreement – Tate & Lyle (LSE:TATE)

    Tate & Lyle has agreed a £2.7 billion takeover by a US rival, marking a significant transaction in the food ingredients sector. The deal highlights ongoing consolidation activity and provides shareholders with a clear valuation benchmark amid a challenging global economic backdrop.

    Sale Process Ends – Audioboom (LSE:BOOM)

    Audioboom has ended its strategic review and abandoned plans for a sale after determining that takeover proposals did not adequately reflect the company’s value. The decision follows record first-half trading performance, with management expressing confidence in the group’s standalone growth prospects.

    Currencies (vs GBP)

    USD: Down (-0.04%), $1.3344

    CHF: Flat (0.12%), Fr.1.06350

    EUR: Up (0.03%), €1.1574

    JPY: Up (0.05%), ¥213.765

    AUD: Up (0.10%), $1.891290

    Bitcoin (BTC/GBP): Down (-0.28%), £47,369.1

    Commodities

    Copper: Up (0.33%), 6.33348

    Gold: Down (-0.45%), 4,308.77

    Brent Crude: Up (4.46%), 96.131

    Natural Gas: Down (-0.91%), 3.144

  • European equities retreat as Middle East tensions flare and AI concerns weigh on sentiment: DAX, CAC, FTSE100

    European equities retreat as Middle East tensions flare and AI concerns weigh on sentiment: DAX, CAC, FTSE100

    European stock markets traded lower on Monday, while oil prices surged, after renewed hostilities between Iran and Israel raised fears over the durability of a U.S.-brokered ceasefire and added fresh uncertainty to global markets.

    By 03:03 ET (07:03 GMT), the pan-European Stoxx 600 had fallen 0.9%. Germany’s DAX dropped 1.3%, France’s CAC 40 declined 0.9%, and the FTSE 100 slipped 0.4%.

    The latest escalation marked the first direct exchange of attacks between Iran and Israel since a fragile truce came into force in April.

    According to media reports, the confrontation was triggered by an Israeli strike on Beirut, the Lebanese capital. Israel has continued to confront Iran-backed Hezbollah forces in Lebanon, although recent clashes had remained relatively contained. Tehran subsequently launched retaliatory attacks, prompting further Israeli military action targeting sites in central and western Iran.

    Israel said on Monday that warning sirens had been activated in response to additional attacks originating from Iran. The country also reported intercepting a ballistic missile fired from Yemen, according to the Wall Street Journal. The newspaper also cited Iran’s Islamic Revolutionary Guard Corps as saying it had targeted airbases in southern Israel.

    Despite the renewed violence, U.S. President Donald Trump said the developments would not derail Washington’s efforts to secure a broader peace agreement with Iran. However, an Iranian official told MS NOW that such a deal is “no longer feasible at this stage.”

    Oil markets reacted sharply to the geopolitical developments. Brent crude, the international benchmark, rose 5.1% to $97.81 per barrel. Although prices remain below previous peaks above $100 per barrel, they are still significantly higher than levels seen before the conflict intensified.

    The rise in energy prices has fuelled concerns that inflationary pressures could re-emerge, potentially prompting central banks, including the European Central Bank, to tighten monetary policy further.

    Government bond yields across the eurozone climbed to multi-week highs, adding pressure to equity markets. Investors are now pricing in as many as three ECB interest rate increases before the end of the year. Bond yields move inversely to prices.

    Beyond geopolitical risks, investors are also reassessing expectations surrounding the artificial intelligence sector. Sentiment weakened following disappointing quarterly results from chipmaker Broadcom (NASDAQ:AVGO) last week, raising questions about the sustainability of the AI-driven market rally.

    A stronger-than-expected U.S. employment report released on Friday further reinforced expectations that the Federal Reserve could maintain a tighter policy stance into 2026.

    European semiconductor stocks moved lower in early trading, reflecting weakness across technology shares in Asia and extending the decline seen on Wall Street at the end of last week.

  • FTSE 100 falls as renewed Iran-Israel conflict sparks flight from risk assets

    FTSE 100 falls as renewed Iran-Israel conflict sparks flight from risk assets

    UK equities opened lower on Monday as investors reacted to a sharp escalation in tensions between Iran and Israel, prompting a move away from risk-sensitive assets and driving energy prices sharply higher.

    The FTSE 100 was down 0.27% in early trading, while losses across continental Europe were more pronounced. Germany’s DAX declined 1.16% and France’s CAC 40 fell 0.86% as markets assessed the implications of the latest military developments in the Middle East.

    Sterling eased marginally against the U.S. dollar, slipping 0.01% to 1.3340. Oil prices surged amid concerns over regional stability and potential supply disruptions. Brent crude rose 4.84% to $97.57 a barrel, while West Texas Intermediate gained 4.42% to $94.54.

    The sell-off followed direct military exchanges between Israel and Iran, marking the most significant escalation since the ceasefire agreed in April. Israeli forces reportedly carried out strikes against military-related targets in western and central Iran, including facilities linked to the Karoun petrochemical complex in Mahshahr.

    Iran responded through the Islamic Revolutionary Guard Corps, which said it had targeted Israeli air bases at Nevatim and Tel Nof as part of what it called Operation Nasr. Further missile launches towards Israel were reported on Monday morning, triggering air raid warnings across Tel Aviv and central parts of the country.

    The situation broadened further as Yemen’s Houthi movement launched additional attacks against Israel and announced a complete ban on Israeli-linked maritime navigation in the Red Sea. Meanwhile, Iran suspended civilian flights at several major airports, and reports indicated widespread internet disruptions across parts of the country.

    Market participants are also closely monitoring developments around the Strait of Hormuz, a key global energy transit route. Iranian officials indicated that future access arrangements could be subject to revised conditions, adding to concerns over potential disruptions to oil shipments.

    Diplomatic efforts continued behind the scenes, with U.S. President Donald Trump reportedly urging restraint in discussions with Israeli Prime Minister Benjamin Netanyahu. However, rhetoric from regional leaders remained confrontational, increasing uncertainty over the direction of the conflict.

    Separately, OPEC+ agreed over the weekend to increase production quotas by 188,000 barrels per day in July in an effort to help stabilise energy markets.

    UK corporate highlights

    Tate & Lyle agrees £2.7 billion takeover offer

    Tate & Lyle (LSE:TATE) announced it has agreed to a £2.7 billion cash acquisition by U.S. ingredients group Ingredion, with shareholders set to receive a substantial premium to the pre-offer share price.

    Debenhams expands into beauty through Revolution partnership

    Debenhams Group (LSE:DEBS) has entered into a licensing agreement with Revolution Beauty (LSE:REVB) to develop fragrance and beauty products under several of its fashion and lifestyle brands, extending its presence into higher-growth consumer categories.

  • Tate & Lyle agrees £2.7 billion cash takeover by Ingredion as shares rally (TATE)

    Tate & Lyle agrees £2.7 billion cash takeover by Ingredion as shares rally (TATE)

    Tate & Lyle Plc (LSE:TATE) shares surged more than 12% after U.S.-based ingredients company Ingredion Incorporated reached an agreement to acquire the British food ingredients and solutions group in a cash transaction valued at approximately £2.7 billion.

    Under the terms of the recommended deal, Tate & Lyle shareholders will receive 595 pence per share in cash. They will also be entitled to a final dividend of up to 13.2 pence per share for the financial year ended 31 March 2026 and an interim dividend of up to 6.8 pence per share for the six months ending 30 September 2026. Including these permitted dividends, the total value of the offer rises to as much as 615 pence per share.

    The cash offer represents a premium of 58.7% to Tate & Lyle’s closing share price on 13 May 2026, the last trading day before the offer period commenced, and a 65.2% premium to the company’s three-month volume-weighted average share price at that date. Including the permitted dividends, the premium increases to 64.0% and 70.8% respectively.

    The transaction values Tate & Lyle at an enterprise value of approximately £3.7 billion based on the cash consideration alone, increasing to around £3.8 billion if the dividends are paid in full. The valuation equates to roughly 8.8 times adjusted EBITDA for the 12 months ended 31 March 2026, before taking account of any anticipated synergies.

    Ingredion’s pursuit of Tate & Lyle followed a five-stage negotiation process that began with an unsolicited proposal of 530 pence per share, structured as 80% cash and 20% Ingredion stock. The Tate & Lyle board rejected that approach, prompting four further proposals before the parties reached agreement on an all-cash offer.

    The combined business is expected to generate approximately $9.9 billion in annual revenue and around $1.8 billion in adjusted EBITDA. Ingredion expects to achieve run-rate net cost synergies of approximately $130 million annually by the end of 2030, with one-off implementation costs estimated at around $175 million.

    David Hearn, chairman of Tate & Lyle, said the board believes “Ingredion’s offer represents an attractive opportunity for shareholders to crystallise value in cash.”

    Support for the transaction has already been secured through irrevocable undertakings covering 76,186,458 shares, representing approximately 17.1% of Tate & Lyle’s issued share capital as of 5 June 2026. This includes the commitment of Huber Equity Corporation, which owns 75 million shares, equivalent to roughly 16.8% of the company.

    Completion of the acquisition remains subject to shareholder approval and regulatory clearances across 12 competition jurisdictions, including the United States, European Union, United Kingdom, China and Brazil. The long-stop date for completion has been set at 8 December 2027.

    More about Tate & Lyle

    Tate & Lyle Plc is a global provider of food and beverage ingredients and solutions, serving customers across a wide range of consumer markets. The company specialises in sweeteners, texturants, fibres and speciality ingredients that help manufacturers improve the nutritional profile, taste and functionality of food and drink products. Through its science-led approach, Tate & Lyle supports customers worldwide in developing healthier and more sustainable products.

  • Audioboom abandons sale process as record first-half performance strengthens independent outlook (BOOM)

    Audioboom abandons sale process as record first-half performance strengthens independent outlook (BOOM)

    Audioboom (LSE:BOOM) has concluded its strategic review and ended discussions regarding a potential sale of the business after determining that proposals received during the process did not adequately reflect the company’s value and growth prospects.

    The board said it received three non-binding cash offers, each at a premium to the share price prior to the launch of the review. However, after evaluating the proposals, directors decided not to pursue a transaction. With no active takeover discussions continuing, Audioboom has exited its offer period and is no longer subject to the enhanced disclosure requirements associated with a potential acquisition process.

    Management said the decision reflects growing confidence in the company’s standalone strategy, supported by continued operational momentum and improving financial performance.

    Trading has remained strong since the start of the year, with the positive trends reported in the first quarter extending into the second quarter. Audioboom now expects to deliver record results for the six months ending 30 June 2026, forecasting revenue of at least $45 million and adjusted EBITDA of no less than $3 million. Both figures are expected to be substantially ahead of the corresponding period last year.

    The upgraded outlook highlights the company’s continued expansion within the podcast advertising market, where increasing audience engagement and advertising demand are supporting growth. Management believes the performance provides reassurance to shareholders that the business can continue to create value independently following the conclusion of the strategic review.

    Audioboom’s outlook reflects a combination of improving profitability and a relatively low-debt balance sheet. However, negative operating and free cash flow reported during 2025 continue to weigh on overall financial quality. Technical indicators remain supportive, with the shares trading above key moving averages and demonstrating strong momentum, although some measures suggest the stock may be approaching overextended levels. Valuation remains reasonable based on earnings metrics, though the absence of a dividend limits income appeal.

    More about Audioboom

    Audioboom Group PLC is a global podcasting platform and one of the largest podcast publishers in both the United States and the United Kingdom. The company’s content reaches more than 50 million unique listeners each month and generates approximately 170 million downloads across its podcast network. Through its proprietary advertising and monetisation platform, Audioboom provides commercial, distribution, production and marketing services to podcast creators and advertisers across North America, Europe, Asia and Australia.

  • SkinBioTherapeutics restates FY25 accounts following investigation into former CEO conduct (SBTX)

    SkinBioTherapeutics restates FY25 accounts following investigation into former CEO conduct (SBTX)

    SkinBioTherapeutics (LSE:SBTX) has published unaudited interim results for the six months ended 31 December 2025, reporting revenue growth of 37.4% to £2.17 million while confirming a series of governance and accounting changes following an investigation into actions taken by its former chief executive.

    The increase in revenue was supported by a full six-month contribution from Bio-Tech Solutions, steady performance from the Dermatonics product range, the rollout of AxisBiotix products into more than 180 Superdrug stores and the receipt of initial licensing income. Gross margins remained broadly stable at approximately 56%, while operating losses narrowed modestly compared with the prior period.

    The company said trading in its AIM-listed shares will be restored following the publication of the results. Management is continuing to focus on expanding the Dermatonics brand, driving cost-effective growth for AxisBiotix, improving operational performance at Bio-Tech Solutions and advancing Zenakine, which recently received industry recognition.

    The reporting period was significantly impacted by the suspension and subsequent resignation of the former CEO after an independent investigation identified fabricated documentation that resulted in the incorrect recognition of approximately £0.77 million in accrued royalty revenue during FY25. The investigation, conducted by FRP Advisory, led to a restatement of FY25 revenue from £4.64 million to £3.87 million and an increase in the reported EBITDA loss.

    While investigators found no concerns relating to the company’s cash balances, the review identified weaknesses in governance processes and issues relating to the timing of bonus-related accounting. In response, SkinBioTherapeutics has implemented a number of corrective measures, including board changes, the repayment of certain bonus payments, enhanced financial controls and the appointment of a new audit firm.

    The company is also pursuing the recovery of approximately £0.7 million in investigation-related costs and is working to rebuild confidence among shareholders, commercial partners and other stakeholders following the findings of the review.

    Although revenue growth remains encouraging and the balance sheet is relatively conservative, the company’s outlook continues to be affected by ongoing losses and weak cash flow generation. Technical indicators also remain negative, with the shares trading below major moving averages and momentum measures remaining under pressure. Valuation support is limited due to the absence of profitability and dividend payments.

    More about SkinBioTherapeutics

    SkinBioTherapeutics is a UK-based life sciences company focused on developing and commercialising microbiome-based technologies for skin health and wellness applications. Its portfolio includes Dermatonics footcare products, AxisBiotix nutritional supplements for blemish-prone skin, Zenakine cosmetic ingredients and the Bio-Tech Solutions manufacturing and services business. The company distributes products through NHS channels, podiatry specialists and major high street retailers while continuing to expand its presence in the consumer health and beauty sectors.